Glutathione, GlutathioneS-Transferase α and π, and Aldehyde Dehydrogenase Content in Relationship to Drug Resistance in Ovarian Cancer

This publication has 20 references indexed in Scilit:

• Mechanisms of drug resistance in ovarian cancer
  Cancer, 2010
• Expression of Glutathione S-Transferase-π in Human Ovarian Cancer as an Indicator of Resistance to Chemotherapy
  Gynecologic Oncology, 1994
• Clinical Reversal of Drug Resistance in Ovarian Cancer
  Gynecologic Oncology, 1993
• Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical Results
  JNCI Journal of the National Cancer Institute, 1992
• Reduced topoisomerase II and elevated α class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C
  Biochemical Pharmacology, 1992
• Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
  Science, 1988
• Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
  Biochemistry, 1988
• Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione
  Biochemical Pharmacology, 1987
• Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion
  Biochemical Pharmacology, 1985